Seeking Alpha

Seeking Alpha Portfolio App for iPad

912 people get ZMH articles and Market Currents by email alert.

Get email alerts on ZMH »

ZMH

Zimmer Holdings, Inc.

5/20/2013, 1:53 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, April 25, 7:17 AM Zimmer Holdings (ZMH): Q1 EPS of $1.41 beats by $0.01. Revenue of $1.14B (-2% Y/Y) in-line . (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, April 5, 4:00 PM Zimmer Holdings (ZMH -1.9%) slips today as Credit Suisse cuts their estimates on the company's Q1 and its reiterated Neutral on the shares. The firm says that it's at the high-end of guidance range, and U.S. knee/hip market growth needs to be more carefully watched. The company lowers its 2013/2014/2015 EPS estimates to $5.74/$6.24/$6.83, from $5.76/$6.30/$6.92 respectively. Comment! [Healthcare, On the Move]
Wednesday, March 20, 4:46 PM Zimmer Holdings (ZMH) says it's announced the launch of Gel-One Cross-linked Hyaluronate at the 2013 American Academy of Orthopaedic Surgeons Annual Meeting today. Gel-One Hyaluronate is an injectable gel approved for the treatment of osteoarthritis of the knee. Comment! [Healthcare]
Friday, March 8, 7:05 AM Zimmer Holdings, Inc. (ZMH) declares $0.20/share quarterly dividend, 11% increase from prior dividend of $0.18. Forward yield 1.06%. For shareholders of record Mar. 29. Payable Apr. 26. Ex-div date Mar. 27. (PR) Comment! [Dividends]
Thursday, January 31, 7:10 AM Zimmer Holdings (ZMH): Q4 EPS of $1.51 beats by $0.01. Revenue of $1.18B (+1.1% Y/Y) beats by $0.01B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, January 31, 12:05 AM Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH Comment! [Earnings]
Wednesday, January 30, 5:30 PM Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH Comment! [Earnings]
Wednesday, January 30, 1:28 PM Zimmer Holdings (ZMH -1%) slips on a downgrade to Hold at Summer Street on valuation. The stock has been on a tear since the beginning of the year, rising nearly 17% on optimism over FDA clearance to market iASSIST Knee for knee replacement procedures. Comment! [Healthcare, On the Move]
Friday, January 18, 2:56 PM Johnson & Johnson (JNJ) has reportedly offered to pay more than $200k per hip case, for a settlement that would top $2B. Johnson & Johnson (JNJ -0.2%) and Zimmer Holding (ZMH -1.8%) have been the subject of thousands of patient lawsuits for their metal-on-metal hip implants, which have been linked to almost 16,800 adverse events in the U.S. between 2000 and 2011. 3 Comments [Healthcare]
Thursday, January 17, 7:44 PM The FDA is concerned whether several medical devices already on the market, such as electroconvulsive therapy devices for depression and emergency defibrillators, require additional evidence to prove they're safe. It's issued a safety advisory, saying patients with symptoms suggesting their devices aren't functioning properly should be considered for testing of possible metal ions in their bloodstream. Symptoms include: skin rashes, neurological changes such as hearing and vision impairment, and psychological status changes including depression. Comment! [Healthcare]
Thursday, January 17, 6:29 PM Zimmer Holdings (ZMH) gets 510(k) clearance from the FDA to market its iASSIST Knee, a Personalized Guidance System for knee replacement procedures. The technology omprises small electronic disposable pod components that are used at the site of knee replacement surgery, and provide instantaneous, accurate alignment validation through a simple electronic display. Comment! [Healthcare]
Friday, December 28, 2012, 12:13 PM The FDA has classified a recent recall of Zimmer's (ZMH -0.8%) Peek Ardis Inserter as Class I, suggesting the product could cause serious health consequences or death. ZMH issued a recall on December 20, after reports of the Interbody Spacer breaking into fragments when too much lateral force is applied to the Ardis Inserter. At the time ZMH warned that if the spacer breaks during implantation, surgical delays of up to 60 minutes could occur and health risks may include a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury. Comment! [Healthcare]
Friday, December 14, 2012, 5:28 PM Zimmer Holdings, Inc. (ZMH) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.07%. For shareholders of record Dec. 27. Payable Jan. 25. Ex-div date Dec. 24. (PR) Comment! [Dividends]
Thursday, October 25, 2012, 7:59 AM Zimmer (ZMH): Q3 EPS of $1.15 beats by $0.02. Revenue of $1.03B (-0.6% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Friday, September 14, 2012, 5:06 PM Zimmer (ZMH) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.08%. For shareholders of record Sep 27. Payable Oct 26. Ex-div date Sep 25. (PR) Comment! [Dividends]
Thursday, July 26, 2012, 7:51 AM Zimmer Holdings (ZMH): Q2 EPS of $1.34 in-line. Revenue of $1.13B (-1.1% Y/Y) misses by $0.01B. (PR) Comment! [Earnings, Healthcare]